Elucidation of the mechanism of action of low-frequency therapy.
- Conditions
- Healthy human
- Registration Number
- JPRN-jRCT1012230046
- Lead Sponsor
- Satoshi Konnno
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
(i) Persons aged 18 years or over at the time of obtaining consent.
(ii) Persons who do not have rheumatoid arthritis, spondyloarthritis, osteoarthritis or interstitial pneumonia
(iii) Persons who understand the purpose of the study and have given their free and voluntary written consent to participate.
(i) Those who have developed acute heart failure, myocardial infarction, pulmonary oedema or acute exacerbation of interstitial pneumonia within the past 3 months.
(ii) Those with a history of cerebral or central nervous system lesions
(iii) Those receiving concomitant vagus nerve stimulation therapy
(iv) Those with a history of epilepsy
(v) Those with a history of severe cardiovascular disease
(vi) Persons with pneumothorax
(vii) Persons with uncontrolled infections
(viii) Pregnant or lactating women
(ix) Persons with skin hypersensitivity and a history of skin symptoms caused by metal or other substances.
(x) Persons with difficulty in oral intake.
(xi) Those with severe renal dysfunction (estimated glomerular filtration rate (eGFR) < 30 ml/min).
(xiii) Persons with a cardiac pacemaker or implantable cardioverter-defibrillator.
Persons who are ineligible to participate in the study on the attached 'MRI Questionnaire'.
(iv) Other subjects who are deemed inappropriate as research subjects by the Principal Investigator or the Research Assigning Physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method